SCHEMBL13809597

SCHEMBL13809597

CC(C)c1ccc(-c2cc(Cl)ccc2Cl)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 12/20 0.52
S1PR5 Q9H228 3/20 0.52
HPGD P15428 4/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPK1 P28482 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 2/20 0.47
SLC9A1 P19634 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 2/20 0.46
PKM P14618 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
ALOX12 P18054 1/20 0.46
HSD17B10 Q99714 1/20 0.46
S1PR2 O95136 5/20 0.45
S1PR3 Q99500 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21119020 0.85 MAPT (0.56) S1PR4S1PR5HPGDHTTMAPT
SCHEMBL19237535 0.82 S1PR4 (0.47) S1PR4S1PR5HPGDHTTMAPT
SCHEMBL9970933 0.79 ALDH1A1 (0.50) S1PR4HPGDHTTMAPTNPSR1
SCHEMBL10028047 0.79 HPGD (0.53) S1PR4S1PR5HPGDHTTMAPT
SCHEMBL13044123 0.76 S1PR4 (0.60) S1PR4S1PR5MAPTNPSR1TDP1
SCHEMBL805123 0.75 HSD17B2 (0.52) S1PR4S1PR5HPGDHTTMAPT
SCHEMBL799579 0.75 HPGD (0.49) S1PR4S1PR5HPGDHTTMAPT
SCHEMBL13809594 0.74 MEN1 (0.54) HPGDHTTMAPTNPSR1TDP1
SCHEMBL18539932 0.73 CD274 (0.50) S1PR4HPGDMAPTNPSR1TDP1
SCHEMBL13078669 0.73 SLC9A1 (0.63) S1PR4S1PR5MAPTNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009078588-A2 COMPOSITION FOR PREVENTION AND TREATMENT OF CANCER CONTAINING PYRIMIDINE DERIVATIVES INHIBITING ACTIVITY OF PROTEIN PHOSPHATASES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-06-25 WO disclosed